SK hynix stock dips on profit-taking as U.S. listing talk resurfaces; earnings next

SK hynix stock dips on profit-taking as U.S. listing talk resurfaces; earnings next

Seoul, Jan 11, 2026, 01:44 KST — Market closed

  • SK hynix shares closed down 1.59% on Friday, lagging the broader market.
  • A Reuters report said the chipmaker is weighing a U.S. listing of treasury shares, with no decision made.
  • Traders now look to U.S. CPI on Jan. 13 and SK hynix’s upcoming results for fresh direction.

SK hynix shares fell 1.59% on Friday as investors took money off the table in semiconductor stocks, KB Securities analyst Lim Jung-eun said. The stock closed at 744,000 won. (Korea Joongang Daily)

The dip came as traders weighed a Reuters report that SK hynix is considering listing treasury shares in the U.S. but has not decided. Treasury shares are stock the company holds in itself, and firms can use them for deals, shareholder returns or other corporate actions. (MarketScreener)

The timing matters because SK hynix has turned into a crowded proxy for the AI supply chain in Seoul, and the stock has sprinted out of the gate this year. A possible U.S. listing, even as an option on the table, adds another lever investors try to price. (MarketScreener)

Demand for memory has become the battleground. Samsung has warned of potential consumer electronics price increases as AI infrastructure buildouts pull memory supply toward data centres, a shift that has tightened parts of the market. (TechRadar)

In product news, SK hynix has pointed to Intel certification for a 256GB DDR5 RDIMM — a server memory module — for Intel’s Xeon 6 platform, according to Evertiq. Sangkwon Lee, head of DRAM product planning at SK hynix, said the company can “respond more swiftly” to customer needs, while Intel executive Dimitrios Ziakas cited “capacity-hungry” AI workloads. (Evertiq)

For traders who live on levels, the stock’s Friday range put 727,000 won in view after the selloff, while the 52-week high sits at 788,000 won, according to Investing.com data. The stock last traded 12,000 won below the prior close. (Investing)

Offshore macro is also in play for Monday’s open. U.S. consumer price data is due on Jan. 13, and it can move bond yields and, by extension, valuations for growth stocks and chip names. The Federal Reserve’s next policy meeting is scheduled for Jan. 27-28. (Bureau of Labor Statistics)

The risk case is familiar but it bites fast: a hotter CPI print can push yields up and pressure tech shares, while any sign that customers are balking at higher memory prices could hit sentiment in a sector that traders still treat as cyclical.

Investors will also keep an eye on whether SK hynix adds detail on any capital-market plans after the Reuters report, and whether the stock’s pullback turns into something more than a one-day reset.

Next up is earnings. SK hynix is due to report quarterly results on Jan. 21, according to an earnings calendar, and the market will listen for comments on high-bandwidth memory demand, pricing and spending plans.

Stock Market Today

  • Teva stock buoyed by high institutional ownership; shares up 3.4% in a week
    January 11, 2026, 8:54 AM EST. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) draws attention from investors for high institutional ownership. Institutions hold about 71% of the shares, with Phoenix Investments & Finances Ltd as the largest holder at 5.3%, followed by about 5.0% and 3.9% holders. The top 25 shareholders together own less than half, indicating a broad base of smaller investors. The stock has risen 3.4% over the past week and has added roughly $1.2 billion to Teva's market cap. Over the past year, shareholders have seen a 53% return. While heavy institutional ownership can influence governance, it can also pose a crowding risk if funds move in unison. Analysts cover Teva; investors should weigh forecasts against company fundamentals.
Roche stock in focus after MediLink cancer-drug deal as investors eye Jan. 29 results
Previous Story

Roche stock in focus after MediLink cancer-drug deal as investors eye Jan. 29 results

P&G stock back in focus after Crest kids toothpaste packaging deal — here’s what’s next
Next Story

P&G stock back in focus after Crest kids toothpaste packaging deal — here’s what’s next

Go toTop